Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 4
2006 9
2007 4
2008 10
2009 9
2010 8
2011 7
2012 10
2013 12
2014 15
2015 13
2016 13
2017 19
2018 9
2019 7
2020 15
2021 15
2022 14
2023 24
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hideomi, yamashita (1 results)?
Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-dose range.
Toita T, Wada K, Sutani S, Umezawa R, Maemoto H, Ii N, Kawamura T, Ikushima H, Takenaka R, Konishi K, Yorozu A, Jingu K, Ariga T, Nomoto Y, Yamashita H. Toita T, et al. Among authors: yamashita h. Jpn J Clin Oncol. 2023 Jun 1;53(6):480-488. doi: 10.1093/jjco/hyad022. Jpn J Clin Oncol. 2023. PMID: 36974716
Recent Advances and Challenges in Stereotactic Body Radiotherapy.
Katano A, Minamitani M, Ohira S, Yamashita H. Katano A, et al. Among authors: yamashita h. Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241229363. doi: 10.1177/15330338241229363. Technol Cancer Res Treat. 2024. PMID: 38321892 Free PMC article. No abstract available.
Efficacy and Safety of Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Interim Analysis from a Multicenter, Open-label, Prospective Phase 2 Trial.
Kimura T, Ishikawa H, Nagumo Y, Sekino Y, Kageyama Y, Ushijima H, Kawai T, Yamashita H, Azuma H, Nihei K, Takemura M, Hashimoto K, Maruo K, Tsuzuki T, Nishiyama H; BPT-ART Investigators Group. Kimura T, et al. Among authors: yamashita h. Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):644-651. doi: 10.1016/j.ijrobp.2023.05.013. Epub 2023 May 15. Int J Radiat Oncol Biol Phys. 2023. PMID: 37196834 Free article. Clinical Trial.
Oligometastases/Oligo-recurrence of lung cancer.
Niibe Y, Chang JY, Onishi H, Salama J, Hiraki T, Yamashita H. Niibe Y, et al. Among authors: yamashita h. Pulm Med. 2013;2013:438236. doi: 10.1155/2013/438236. Epub 2013 Feb 14. Pulm Med. 2013. PMID: 23476762 Free PMC article. No abstract available.
Standardization of imaging features for radiomics analysis.
Haga A, Takahashi W, Aoki S, Nawa K, Yamashita H, Abe O, Nakagawa K. Haga A, et al. Among authors: yamashita h. J Med Invest. 2019;66(1.2):35-37. doi: 10.2152/jmi.66.35. J Med Invest. 2019. PMID: 31064950 Free article.
211 results